It should be noted, however, that these studies consistently showed that loss of Kindlin-2 function does not lead to total elimination of invasion and metastasis, possibly because both shRNA knockdown and CRISPR/Cas9-mediated knockout used in these studies did not result in complete loss of Kindlin-2 expression in the cancer cells. Here, FERMT2 is linked to cancer.